» Articles » PMID: 36851696

Deubiquitinating Enzyme Inhibitors Block Chikungunya Virus Replication

Overview
Journal Viruses
Publisher MDPI
Specialty Microbiology
Date 2023 Feb 28
PMID 36851696
Authors
Affiliations
Soon will be listed here.
Abstract

Ubiquitination and deubiquitination processes are widely involved in modulating the function, activity, localization, and stability of multiple cellular proteins regulating almost every aspect of cellular function. Several virus families have been shown to exploit the cellular ubiquitin-conjugating system to achieve a productive infection: enter the cell, promote genome replication, or assemble and release viral progeny. In this study, we analyzed the role of deubiquitinating enzymes (DUBs) during chikungunya virus (CHIKV) infection. HEK293T, Vero-E6, and Huh-7 cells were treated with two DUB inhibitors (PR619 or WP1130). Then, infected cells were evaluated by flow cytometry, and viral progeny was quantified using the plaque assay method. The changes in viral proteins and viral RNA were analyzed using Western blotting and RT-qPCR, respectively. Results indicate that treatment with DUB inhibitors impairs CHIKV replication due to significant protein and viral RNA synthesis deregulation. Therefore, DUB activity may be a pharmacological target for blocking CHIKV infection.

Citing Articles

Host-Driven Ubiquitination Events in Vector-Transmitted RNA Virus Infections as Options for Broad-Spectrum Therapeutic Intervention Strategies.

Sreepangi S, Baha H, Opoku L, Jones N, Konadu M, Alem F Viruses. 2024; 16(11).

PMID: 39599842 PMC: 11599102. DOI: 10.3390/v16111727.


TRIM32 inhibits Venezuelan equine encephalitis virus infection by targeting a late step in viral entry.

Xie Y, Cao J, Gan S, Xu L, Zhang D, Qian S PLoS Pathog. 2024; 20(11):e1012312.

PMID: 39527628 PMC: 11581401. DOI: 10.1371/journal.ppat.1012312.


Design and testing of Hepatitis Delta Ribozymes for suppression of Chikungunya virus infection in cell cultures.

Fraser M, Kucharski C, Loh Z, Hanahoe E, Fraser Jr M Med Res Arch. 2024; 12(8).

PMID: 39324067 PMC: 11423935. DOI: 10.18103/mra.v12i8.5762.


TRIM32 inhibits Venezuelan Equine Encephalitis Virus Infection by targeting a late step in viral entry.

Xie Y, Cao J, Gan S, Xu L, Zhang D, Qian S bioRxiv. 2024; .

PMID: 38895352 PMC: 11185716. DOI: 10.1101/2024.06.04.597282.


Special Issue "Chikungunya Virus and Emerging Alphaviruses".

Pereira M, Franca R Viruses. 2023; 15(8).

PMID: 37632110 PMC: 10457814. DOI: 10.3390/v15081768.

References
1.
Dhanwani R, Khan M, Lomash V, Rao P, Ly H, Parida M . Characterization of chikungunya virus induced host response in a mouse model of viral myositis. PLoS One. 2014; 9(3):e92813. PMC: 3965460. DOI: 10.1371/journal.pone.0092813. View

2.
Karpe Y, Pingale K, Kanade G . Activities of proteasome and m-calpain are essential for Chikungunya virus replication. Virus Genes. 2016; 52(5):716-21. PMC: 7088676. DOI: 10.1007/s11262-016-1355-5. View

3.
Akutsu M, Dikic I, Bremm A . Ubiquitin chain diversity at a glance. J Cell Sci. 2016; 129(5):875-80. DOI: 10.1242/jcs.183954. View

4.
Kaur P, Lello L, Utt A, Dutta S, Merits A, Chu J . Bortezomib inhibits chikungunya virus replication by interfering with viral protein synthesis. PLoS Negl Trop Dis. 2020; 14(5):e0008336. PMC: 7286522. DOI: 10.1371/journal.pntd.0008336. View

5.
Nair S, Abraham R, Sundaram S, Sreekumar E . Interferon regulated gene (IRG) expression-signature in a mouse model of chikungunya virus neurovirulence. J Neurovirol. 2017; 23(6):886-902. DOI: 10.1007/s13365-017-0583-3. View